1. Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Pharma/Biotech Companies - In the News

For the discussion of current news articles in the pharma/biotech space. Please provide a link to the article, and do not cut and paste whole articles due to copyright restrictions.


Sort By:
Title
Replies Views
Last Message ↓
  1. cafead
    Replies:
    0
    Views:
    62
  2. cafead
    Replies:
    0
    Views:
    32
  3. cafead
    Replies:
    0
    Views:
    50
  4. cafead
    Replies:
    0
    Views:
    30
  5. cafead
    Replies:
    0
    Views:
    29
  6. cafead
    Replies:
    0
    Views:
    38
  7. cafead
    Replies:
    0
    Views:
    31
  8. cafead
    Replies:
    0
    Views:
    27
  9. cafead
    Replies:
    0
    Views:
    48
  10. cafead
    Replies:
    0
    Views:
    28
  11. cafead
    Replies:
    0
    Views:
    27
  12. cafead
    Replies:
    0
    Views:
    25
  13. cafead
    Replies:
    0
    Views:
    25
  14. cafead
    Replies:
    0
    Views:
    33
  15. cafead
    Replies:
    0
    Views:
    24
  16. cafead
    Replies:
    0
    Views:
    24
  17. cafead
    Replies:
    0
    Views:
    23
  18. cafead
    Replies:
    0
    Views:
    24
  19. cafead
    Replies:
    0
    Views:
    23
  20. cafead
    Replies:
    0
    Views:
    23

Thread Display Options

Loading...